Torelli GF, Chiaretti S, Peragine N, Barberi W, et al. Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial. Am J Hematol 2022 Mar 22. doi: 10.1002/ajh.26537.
PMID: 35315128